StockData

Assembly Biosciences vs NanoViricides

ASMB and NNVC side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ASMB and NNVC compare

Assembly Biosciences is the larger company, worth 15 times as much as NanoViricides ($458M against $29.6M).

Assembly Biosciences scores higher on the StockData Score (12 against 5 for NanoViricides), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricASMBNNVC
Size and price
Market cap$458M$29.6M
Share price$22.50$1.16
Change, 1 year−38.7%−18.3%
Change, 5 years−20.2%−76.1%
Beta (5Y)0.931.91
Employees737
StockData Score
Total score12 (better)5
Valuation score2 (better)0
Growth score1 (better)0
Performance score3 (better)0
Health score6 (better)5
Dividend score00
Valuation
P/S6.1×–
P/B1.5× (better)3.4×
FCF yield−8.4% (better)−26.3%
Fair value$24.69–
Margin of safety8.9%–
Growth
Revenue growth (TTM)125%–
Revenue growth, 5Y average−1.8%–
Profitability
Operating margin−11.8%–
Net margin−0.06%–
FCF margin−51.5%–
Return on equity−0.03% (better)−101%
Return on invested capital–−111%
Financial health
Debt / equity0.000.00
Current ratio13.99 (better)2.66
Altman Z-score8.58 (better)−10.00
Piotroski F-score4 (better)3
Dividends and buybacks
Buyback yield0.00% (better)−6.4%
Shareholder yield0.00% (better)−6.4%
Ownership
Held by institutions92.1%9.3%
Held by insiders29.3%0.00%
Insider net buying, 12 months−$252K–
Short interest, % of float21.1%3.2%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.